English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 849014      Online Users : 1506
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10777


    Title: Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma
    Authors: Li, SM;Chen, CH;Chen, YW;Yen, YC;Fang, WT;Tsai, FY;Chang, JL;Shen, YY;Huang, SF;Chuu, CP;Chang, IS;Hsiung, CA;Jiang, SS
    Contributors: Institute of Population Health Sciences;National Institute of Cancer Research;Pathology Core Laboratory;Institute of Molecular and Genomic Medicine;Institute of Cellular and Systems Medicine
    Abstract: CISD2 is a redox-sensitive gene critical for normal development and mitochondrial integrity. CISD2 was known to have aberrant expression in several types of human cancers. However, its relation with lung cancer is still not clear. In this study we found CISD2 mRNA was significantly upregulated in lung adenocarcinoma (ADC) samples, compared with their adjacent normal counterparts, and was correlated with tumor stage, grade, and prognosis based on analysis of clinical specimens-derived expression data in public domain and our validation assay. Cell based assay indicated that CISD2 expression regulated accumulation of reactive oxygen species (ROS), polarization of mitochondrial membrane potential, as well as cell viability, apoptosis, invasiveness, and tumorigenicity. In addition, CISD2 expression was found significantly correlated with stress response/redox signaling genes such as EGR1 and GPX3, while such correlations were also found valid in many public domain data. Taken together, upregulation of CISD2 is involved in an increased antioxidant capacity in response to elevated ROS levels during the formation and progression of lung ADC. The molecular mechanism underlying how CISD2 regulates ROS homeostasis and augments malignancy of lung cancer warrants further investigations.
    Date: 2017-09-19
    Relation: Scientific Reports. 2017 Sep 19;7:Article number 11893.
    Link to: http://dx.doi.org/10.1038/s41598-017-12131-x
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2045-2322&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000411165100070
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85029830796
    Appears in Collections:[熊昭] 期刊論文
    [江士昇] 期刊論文
    [張憶壽] 期刊論文
    [陳雅雯] 期刊論文
    [沈瑩瑩] 期刊論文
    [黃秀芬] 期刊論文
    [褚志斌] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PUB28928421.pdf3965KbAdobe PDF454View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback